[1]王怡博,冯广森.左侧桡动脉和右侧桡动脉入路TACE治疗的对比分析[J].介入放射学杂志,2023,32(12):1226-1229.
　WANG Yibo,FENG Guangsen..Left transradial approach versus right transradial approach for TACE treatment： a comparative study[J].journal interventional radiology,2023,32(12):1226-1229.
点击复制

左侧桡动脉和右侧桡动脉入路TACE治疗的对比分析()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年12
页码:
1226-1229
栏目:
临床研究
出版日期:
2024-01-02

文章信息/Info

Title:
Left transradial approach versus right transradial approach for TACE treatment： a comparative study
作者:
王怡博;  冯广森
Author(s):
WANG Yibo;  FENG Guangsen.
Department of Interventional Radiology， Henan Provincial Hospital of Traditional Chinese Medicine， Zhengzhou， Henan Province 450002， China
关键词:
【关键词】 肝癌;  肝动脉化疗栓塞术;  桡动脉入路
文献标志码:
A
摘要:
【摘要】 目的 分析比较左右侧桡动脉不同入路在TACE手术治疗中的影响。方法 回顾性分析了2021年6月至2022年5月在河南省中医院接受常规TACE治疗的174例肝癌患者，其中小于65岁：左侧桡动脉入路52例，右侧桡动脉入路54例；大于65岁：左侧桡动脉入路32例，右侧桡动脉入路36例。对比分析左侧桡动脉入路和右侧桡动脉入路的并发症发生情况，插管至腹腔干的透视时间、手术整体透视时间和射线剂量。结果 小于65岁患者中左侧桡动脉入路组和右侧桡动脉入路组插管至腹腔干透视时间、手术整体透视时间、射线剂量及穿刺点并发症发生率差异无统计学意义（P＞0.05）；在大于65岁患者中，左侧桡动脉入路和右侧桡动脉入路的穿刺点并发症发生率未见明显差异，无统计学意义（P＞0.05）。左侧桡动脉入路插管至腹腔干透视时间、手术整体透视时间及射线剂量均低于右侧桡动脉入路［（60.3±28.3） s vs (86.3±45.2） s， P＝0.003］；［（11.2±4.5） min vs （14.3±6.3） min，P＝0.030］；［（452.2±121.7） mGy vs （563.8±181.5） mGy，P＝0.022］，差异有统计学意义。结论 左侧桡动脉入路和右侧桡动脉入路在常规TACE治疗中穿刺点并发症发生率没有明显差异，但左侧桡动脉入路在大于65岁的老年患者中能明显减少手术透视时间和射线剂量。

参考文献/References:

［1］ 江海林，孟小茜，廖华强，等． 经桡动脉途径行外周介入的安全性与可行性［J］． 介入放射学杂志， 2018， 27：1027-1030．

［2］ Zhang X， Luo Y， Tsauo J， et al. Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma： a randomized trial［J］. Eur Radiol， 2022， 32： 6812-6819.

［3］ Iezzi R， Pompili M， Posa A， et al. Transradial versus transfemoral access for hepatic chemoembolization： intrapatient prospective single-center study［J］. J Vasc Interv Radiol， 2017， 28： 1234-1239.

［4］ Liu LB， Cedillo MA， Bishay V， et al. Patient experience and preference in transradial versus transfemoral access during transarterial radioembolization： a randomized single-center trial［J］. J Vasc Interv Radiol， 2019， 30： 414-420.

［5］ Pancholy SB， Joshi P， Shah S， et al. Effect of vascular access site choice on radiation exposure during coronary angiography： the REVERE trial（randomized evaluation of vascular entry site and radiation exposure）［J］. JACC Cardiovasc Interv， 2015， 8： 1189-1196.

［6］ Kis B， Mills M， Hoffe SE. Hepatic radioembolization from transradial access： initial experience and comparison to transfemoral access［J］. Diagn Interv Radiol， 2016， 22： 444-449.

［7］ 张秩源，王 勇，徐 浩，等． 经桡动脉及股动脉入路对肝癌患者行TACE的前瞻性研究［J］． 医学影像学杂志， 2022， 32：254-258．

［8］ Wang L， Zhang J， Xin S. Morphologic features of the aortic arch and its branches in the adult Chinese population［J］. J Vasc Surg， 2016， 64： 1602-1608.e1.

［9］ Bishay VL， Biederman DM， Ward TJ， et al. Transradial approach for hepatic radioembolization： initial results and technique［J］. AJR Am J Roentgenol， 2016， 207： 1112-1121.

［10］ Kumar AJ， Jones LE， Kollmeyer KR， et al. Radial artery access for peripheral endovascular procedures［J］. J Vasc Surg， 2017， 66： 820-825.

［11］ Shah B， Burdowski J， Guo Y， et al. Effect of left versus right radial artery approach for coronary angiography on radiation parameters in patients with predictors of transradial access failure［J］. Am J Cardiol， 2016， 118： 477-481.

［12］ 江海林，孟小茜，廖华强，等． 不同体位经桡动脉途径行TACE术的透视时间对比［J］． 介入放射学杂志， 2021， 30：275-278．

［13］ Al?蛳Hakim R， Gandhi RT， Benenati JF. Incident of stroke after transradial arterial access for subdiaphragmatic intervention［J］. J Vasc Interv Radiol ， 2017， 28： 1287-1288.

［14］ Roy AK， Garot P， Louvard Y， et al. Comparison of transradial vs transfemoral access for aortoiliac and femoropopliteal interventions： a single-center experience［J］. J Endovasc Ther， 2016， 23： 880-888.

［15］ Hung ML， Lee EW， McWilliams JP， et al. A reality check in transradial access： a single-centre comparison of transradial and transfemoral access for abdominal and peripheral intervention［J］. Eur Radiol， 2019， 29： 68-74.

 

相似文献/References:

[1]叶更新,曾文,杜德坤,等.肝动脉栓塞与经皮碘油标记酒精注射联合治疗晚期肝癌[J].介入放射学杂志,1996,(01):42.
[2]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
　.Ｔｈｅ ｖｏｌｕｍｅ ｏｆ Ｌｉｐｉｏｄｏｌ ｕｓｅｄ ｉｎ ＴＡＣＥ： ｉｔｓ ｃｕｒｒｅｎｔ ｓｉｔｕａｔｉｏｎ ａｎｄ ｒｅｓｅａｒｃｈ ｐｒｏｇｒｅｓｓ [J].journal interventional radiology,2012,(12):348.
[3]施长杲,吕维富,鲁 东,等.肝动脉化疗栓塞术后并发肝脓肿５例治疗分析[J].介入放射学杂志,2011,(04):273.
　SHI Chang-gao,LV Wei-fu,LU Dong,et al.The treatment of liver abscess occurred after transcatheter arterial chemoembolization report of five cases[J].journal interventional radiology,2011,(12):273.
[4]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
　,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(12):322.
[5]张　　　磊,陆骊工,李　　　勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
　ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(12):968.
[6]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
　AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(12):1010.
[7]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
　DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(12):75.
[8]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
　ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(12):78.
[9]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
　HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(12):682.
[10]刘纪营,马 南,管 生,等. 预防性应用抗生素的不同方法对介入治疗并发肝脓肿的影响[J].介入放射学杂志,2013,(06):474.
　LIU Ji? ying,MA Nan,GUAN Sheng,et al. The influence of different using methods of antibiotic prophylaxis on the occurrence of liver abscess after transcatheter hepatic arterial chemoembolization[J].journal interventional radiology,2013,(12):474.
[11]纪建红,郑群丽,陈思倩,等.TACE联合射频消融术治疗巨块型肝癌的护理[J].介入放射学杂志,2013,(12):1052.
　JI Jian? hong,ZHENG Qun? li,CHEN Si? qian,et al.Nursing care for patients with massive hepatocellular carcinoma receiving combination therapy of TACE and radiofrequency ablation[J].journal interventional radiology,2013,(12):1052.
[12]臧 爽,徐 阳,梁松年.原发性肝癌患者经肝动脉化疗栓塞术后住院天数影响因素的多元线性回归分析[J].介入放射学杂志,2015,(01):80.
　ZANG Shuang,XU Yang,LIANG Song nian..Multiple linear regression analysis of factors related to the hospitalization days in HCC patients after transcatheter hepatic arterial chemoembolization[J].journal interventional radiology,2015,(12):80.
[13]任文君,王泽阳,黄 欣,等.肝动脉化疗栓塞术联合125I放射性粒子植入术与单独肝动脉化疗栓塞术治疗肝癌的meta分析[J].介入放射学杂志,2019,28(02):132.
　REN Wenjun,WANG Zeyang,HUANG Xin,et al.TACE combined with 125I seed implantation vs simple TACE for the treatment of liver cancer： a meta analysis[J].journal interventional radiology,2019,28(12):132.
[14]赵凯凯,司友娇,黄九宁,等.肝癌患者TACE术后对比剂肾病的危险因素[J].介入放射学杂志,2019,28(10):942.
　ZHAO Kaikai,SI Youjiao,HUANG Jiuning,et al.The risk factors for contrast- induced nephropathy in patients with HCC after TACE[J].journal interventional radiology,2019,28(12):942.
[15]江海林,孟小茜,廖华强,等.不同体位经桡动脉途径行TACE术的透视时间对比[J].介入放射学杂志,2021,30(03):275.
　JIANG Hailin,MENG Xiaoxi,LIAO Huaqiang,et al.Comparison of fluoroscopic time between different body positions in performing TACE via radial approach[J].journal interventional radiology,2021,30(12):275.
[16]李虎子,段振东,赵 成,等.TACE联合冷冻消融治疗不可切除肝癌临床疗效的meta分析[J].介入放射学杂志,2021,30(08):804.
　LI Huzi,DUAN Zhendong,ZHAO Cheng,et al.TACE combined with cryoablation for inoperable liver cancers： a meta analysis of clinical efficacy[J].journal interventional radiology,2021,30(12):804.
[17]刘秀芳,张伟伟,吴海平,等.多学科协作干预模式在TACE治疗原发性肝癌患者中的应用效果 [J].介入放射学杂志,2021,30(10):1057.
　LIU Xiufang,ZHANG Weiwei,WU Haiping,et al.The application value of multi-disciplinary team intervention mode in HCC patients receiving TACE[J].journal interventional radiology,2021,30(12):1057.
[18]梁 轶,严忠婷,桑玉还,等.肝癌患者肝动脉化疗栓塞术后恶心和呕吐的危险因素及评估工具研究进展[J].介入放射学杂志,2024,33(05):565.
　LIANG Yi,YAN Zhongting,SANG Yuhuan,et al.Research progress in risk factors and evaluation tools for nausea and vomiting after hepatic artery chemoembolization in liver cancer patients[J].journal interventional radiology,2024,33(12):565.

备注/Memo

备注/Memo:
（收稿日期：2022-11-15）

（本文编辑：茹 实）
更新日期/Last Update: 2024-01-02